Pfizer hires Novartis oncology exec to steer its cancer ambitions

After promoting its oncology officer Chris Boshoff to chief scientific officer last fall, Pfizer has found his successor.

Jeff Legos, the global …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028 – Biotech Investments

PolyPeptide Group / Key word(s): Half Year Results 13-Aug-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

August 14, 2024

$10,000 experiment uncovers what makes us happiest

People across diverse countries experienced greater happiness by spending on others, experiences, and personal growth, with cultural and economic contexts shaping the emotional impact of

January 2, 2025

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons – Biotech Investments

EQS-News: BRAIN Biotech AG / Key word(s): Personnel Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons 03.10.2024 / 14:00

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.